- Home
- GRDX vs TNON Comparison
GRDX vs TNON Comparison
Compare GRDX & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$2.44
HOLD
Current Price
$0.81
Company Overview
Basic Information| Metric | GRDX | TNON |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United Kingdom | United States |
| Employees | N/A | 27 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1M | 9.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GRDX | TNON |
|---|---|---|
| Price | $2.44 | $0.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 142.7K | ★ 1.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $19.56 |
| Revenue Next Year | N/A | $71.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.92 | $0.64 |
| 52 Week High | $5.30 | $5.85 |
Technical Indicators
Market Signals| Indicator | GRDX | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 41.96 | 45.99 |
| Support Level | $2.03 | $0.64 |
| Resistance Level | $3.41 | $1.18 |
| Average True Range (ATR) | 0.37 | 0.07 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 26.67 | 63.53 |
Price Performance
Historical Comparison GRDX
TNON
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.